Autologous mobilized peripheral blood CD34+ cell infusion in non-viral decompensated liver cirrhosis

Table 3 Comparison between control and study group at 3 mo (mean ± SD)

Parameter	Control group (n = 17)	Study group(n = 18)	P value
Platelet count (Lakhs/mm3)	0.91 ± 0.36	1.16 ± 0.71	0.21
Total bilirubin (mg/dL)	5.89 ± 7.13	3.82 ± 3.30	0.27
AST (IU/mL)	70.29 ± 43.57	48.39 ± 15.79	0.05
ALT (IU/mL)	49.18 ± 66.59	39.44 ± 19.02	0.55
Albumin (mg/dL)	2.65 ± 0.53	2.83 ± 0.33	0.24
INR	1.88 ± 0.48	1.61 ± 0.30	0.05
Creatinine (mg/dL)	1.42 ± 0.70	0.96 ± 0.33	0.01
MELD score	19.94 ± 6.68	15.75 ± 5.13	0.04
Frequency of tap in last 3 mo	1.59 ± 1.06	1.28 ± 0.75	0.32

AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; IU: International unit; INR: International normalized ratio; MELD: Model for end-stage liver disease score; tap: Therapeutic paracentesis.